跳转至内容
Merck
CN
  • PDGF signaling from pharyngeal pouches promotes arch artery morphogenesis.

PDGF signaling from pharyngeal pouches promotes arch artery morphogenesis.

Journal of genetics and genomics = Yi chuan xue bao (2020-01-25)
Aihua Mao, Mingming Zhang, Jie Liu, Yu Cao, Qiang Wang
摘要

The great vessels of the heart originate from the pharyngeal arch arteries (PAAs). Anomalies of the PAAs often occur together with pharyngeal pouch malformations, but the reasons for this phenomenon are not fully understood. In the current study, we show that platelet-derived growth factor (PDGF) signaling derived from the pharyngeal pouches plays an important function in PAA vasculogenesis. During PAA development in zebrafish embryos, pdgfαa and pdgfαb are expressed in the developing pharyngeal pouches. Results from loss-of-function experiments revealed a critical role of these genes in PAA formation. We found that nitroreductase (NTR)-mediated pouch ablation distinctly decreased PDGF receptor tyrosine phosphorylation, yielding a severe loss of PAAs. Importantly, pouch-specific overexpression of pdgfαa in pdgfαa-/-; pdgfαb-/- mutants significantly relieved the PAA defects, which indicated a primary role of pharyngeal pouch-expressed PDGF ligands in signal activation and PAA morphogenesis. Our findings further showed that PDGF signaling was indispensable for the proliferation of PAA angioblasts. Together, these results established a role for PDGFαa- and PDGFαb-mediated tissue-tissue interaction during PAA development.

材料
货号
品牌
产品描述

Sigma-Aldrich
甲硝唑, BioXtra
Sigma-Aldrich
曲西瑞宾 水合物, ≥97% (HPLC)
Sigma-Aldrich
PDGFR Tyrosine Kinase Inhibitor V, The PDGFR Tyrosine Kinase Inhibitor V, also referenced under CAS 347155-76-4, controls the biological activity of PDGFR Tyrosine Kinase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.